- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The Immuno-Oncology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Immuno-Oncology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 14.3%% in the forecast period of 2020 to 2025 and will expected to reach USD 56950 million by 2025, from USD 33390 million in 2019.
Market segmentation
Immuno-Oncology market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Immuno-Oncology market has been segmented into Immune Checkpoint Inhibitors, Cytokine-Based Immunotherapy, Cancer Vaccines, CAR-T Cell Therapy, Others, etc.
Breakdown by Application, Immuno-Oncology has been segmented into Hospitals, Drugstores, Others, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Immuno-Oncology market presented in the report. This section sheds light on the sales growth of different regional and country-level Immuno-Oncology markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Immuno-Oncology market.
For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Immuno-Oncology Market Share Analysis
Immuno-Oncology competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Immuno-Oncology revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Immuno-Oncology revenue and market share for each player covered in this report.
The major players covered in Immuno-Oncology are: Bristol-Myers Squibb, Gilead Sciences Inc., AstraZeneca, Plc, Merck & Co., Inc., Novartis, Roche AG, Dendreon Pharmaceuticals, Sanofi S.A., Merck KGaA, etc. Among other players domestic and global, Immuno-Oncology market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Market segment by players, this report covers
Bristol-Myers Squibb
Gilead Sciences Inc.
AstraZeneca, Plc
Merck & Co., Inc.
Novartis
Roche AG
Dendreon Pharmaceuticals
Sanofi S.A.
Merck KGaA
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
MENA (Saudi Arabia, UAE, Turkey and South Africa)
Market segment by Type, covers:
Immune Checkpoint Inhibitors
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Others
Market segment by Application, can be divided into
Hospitals
Drugstores
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Immuno-Oncology
1.2 Classification of Immuno-Oncology by Type
1.2.1 Overview: Global Immuno-Oncology Revenue by Type: 2015 Versus 2019 Versus 2025
1.2.2 Global Immuno-Oncology Revenue Market Share by Type in 2019
1.2.3 Immune Checkpoint Inhibitors
1.2.4 Cytokine-Based Immunotherapy
1.2.5 Cancer Vaccines
1.2.6 CAR-T Cell Therapy
1.2.7 Others
1.3 Global Immuno-Oncology Market by Application
1.3.1 Overview: Global Immuno-Oncology Revenue by Application: 2015 Versus 2019 Versus 2025
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Global Immuno-Oncology Market Size and Forecast (2015-2025)
1.5 Global Immuno-Oncology Market Size by Regions: 2015 VS 2019 VS 2025
1.6 Global Immuno-Oncology Market Size by Regions (2015-2020)
1.7 Global Immuno-Oncology Market Size and Forecast by Regions (2020-2025)
1.7.1 North America Immuno-Oncology Status and Prospect (2015-2025)
1.7.2 Europe Immuno-Oncology Status and Prospect (2015-2025)
1.7.3 Asia Immuno-Oncology Status and Prospect (2015-2025)
1.7.4 South America Immuno-Oncology Status and Prospect (2015-2025)
1.7.5 Middle East & Africa Immuno-Oncology Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business
2.1.3 Bristol-Myers Squibb SWOT Analysis
2.1.4 Bristol-Myers Squibb Product and Services
2.1.5 Bristol-Myers Squibb Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.2 Gilead Sciences Inc.
2.2.1 Gilead Sciences Inc. Details
2.2.2 Gilead Sciences Inc. Major Business
2.2.3 Gilead Sciences Inc. SWOT Analysis
2.2.4 Gilead Sciences Inc. Product and Services
2.2.5 Gilead Sciences Inc. Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.3 AstraZeneca, Plc
2.3.1 AstraZeneca, Plc Details
2.3.2 AstraZeneca, Plc Major Business
2.3.3 AstraZeneca, Plc SWOT Analysis
2.3.4 AstraZeneca, Plc Product and Services
2.3.5 AstraZeneca, Plc Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck & Co., Inc.
2.4.1 Merck & Co., Inc. Details
2.4.2 Merck & Co., Inc. Major Business
2.4.3 Merck & Co., Inc. SWOT Analysis
2.4.4 Merck & Co., Inc. Product and Services
2.4.5 Merck & Co., Inc. Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.6 Roche AG
2.6.1 Roche AG Details
2.6.2 Roche AG Major Business
2.6.3 Roche AG Product and Services
2.6.4 Roche AG Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.7 Dendreon Pharmaceuticals
2.7.1 Dendreon Pharmaceuticals Details
2.7.2 Dendreon Pharmaceuticals Major Business
2.7.3 Dendreon Pharmaceuticals Product and Services
2.7.4 Dendreon Pharmaceuticals Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sanofi S.A.
2.8.1 Sanofi S.A. Details
2.8.2 Sanofi S.A. Major Business
2.8.3 Sanofi S.A. Product and Services
2.8.4 Sanofi S.A. Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)
2.9 Merck KGaA
2.9.1 Merck KGaA Details
2.9.2 Merck KGaA Major Business
2.9.3 Merck KGaA Product and Services
2.9.4 Merck KGaA Immuno-Oncology Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Immuno-Oncology Market Size by Players (2015-2020)
3.2 China Immuno-Oncology Market Size by Players (2015-2020)
3.3 Market Concentration Rate
3.3.1 Top 5 Immuno-Oncology Players Market Share
3.3.2 Top 10 Immuno-Oncology Players Market Share
4 North America Market Size and Forecast by Countries
4.1 North America Immuno-Oncology Market Size by Countries (2015-2020)
4.2 North America Immuno-Oncology Market Size and Forecast by Countries (2015-2026)
4.3 United States Immuno-Oncology Market Size and Forecast (2015-2025)
4.4 Canada Immuno-Oncology Market Size and Forecast (2015-2025)
4.5 Mexico Immuno-Oncology Market Size and Forecast (2015-2025)
5 Europe Market Size and Forecast by Countries
5.1 Europe Immuno-Oncology Market Size by Countries (2015-2020)
5.2 Europe Immuno-Oncology Market Size and Forecast by Countries (2015-2026)
5.3 Germany Immuno-Oncology Market Size and Forecast (2015-2025)
5.4 France Immuno-Oncology Market Size and Forecast (2015-2025)
5.5 UK Immuno-Oncology Market Size and Forecast (2015-2025)
5.6 Russia Immuno-Oncology Market Size and Forecast (2015-2025)
5.7 Italy Immuno-Oncology Market Size and Forecast (2015-2025)
6 Asia-Pacific Market Size and Forecast by Countries
6.1 Asia-Pacific Immuno-Oncology Market Size by Regions (2015-2020)
6.2 Asia-Pacific Immuno-Oncology Market Size and Forecast by Regions (2015-2026)
6.3 China Immuno-Oncology Market Size and Forecast (2015-2025)
6.4 Japan Immuno-Oncology Market Size and Forecast (2015-2025)
6.5 Korea Immuno-Oncology Market Size and Forecast (2015-2025)
6.6 India Immuno-Oncology Market Size and Forecast (2015-2025)
6.7 Southeast Asia Immuno-Oncology Market Size and Forecast (2015-2025)
7 South America Market Size and Forecast by Countries
7.1 South America Immuno-Oncology Market Size by Countries (2015-2020)
7.2 South America Immuno-Oncology Market Size and Forecast by Countries (2015-2026)
7.3 Brazil Immuno-Oncology Market Size and Forecast (2015-2025)
7.4 Argentina Immuno-Oncology Market Size and Forecast (2015-2025)
8 Middle East & Africa Market Size and Forecast by Countries
8.1 Middle East & Africa Immuno-Oncology Revenue by Regions (2015-2020)
8.2 Middle East & Africa Immuno-Oncology Market Size and Forecast by Countries (2015-2026)
8.3 Saudi Arabia Immuno-Oncology Market Size and Forecast (2015-2025)
8.4 UAE Immuno-Oncology Market Size and Forecast (2015-2025)
8.5 Egypt Immuno-Oncology Market Size and Forecast (2015-2025)
8.6 South Africa Immuno-Oncology Market Size and Forecast (2015-2025)
9 Market Size Segment by Type
9.1 Global Immuno-Oncology Market Size and Forecast by Type (2015-2025)
9.1.1 Global Immuno-Oncology Market Size by Type (2015-2020)
9.1.2 Global Immuno-Oncology Market Size Forecast by Type (2020-2025)
9.2 China Immuno-Oncology Market Size and Forecast by Type (2015-2025)
9.2.1 China Immuno-Oncology Market Size by Type (2015-2020)
9.2.2 China Immuno-Oncology Market Size Forecast by Type (2020-2025)
10 Market Size Segment by Application
10.1 Global Immuno-Oncology Market Size and Forecast by Application (2015-2025)
10.1.1 Global Immuno-Oncology Market Size by Application (2015-2020)
10.1.2 Global Immuno-Oncology Market Size Forecast by Application (2020-2025)
10.2 China Immuno-Oncology Market Size and Forecast by Application (2015-2025)
10.2.1 China Immuno-Oncology Market Size by Application (2015-2020)
10.2.2 China Immuno-Oncology Market Size Forecast by Application (2020-2025)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Data Source
12.3 Disclaimer
12.4 About US
List of Tables
Table 1. Global Immuno-Oncology Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025
Table 2. Breakdown of Immuno-Oncology by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Immuno-Oncology Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025
Table 4. Global Market Immuno-Oncology Market Size (USD Million) Comparison by Regions (2020-2025)
Table 5. Global Immuno-Oncology Revenue (USD Million) by Regions (2015-2020)
Table 6. Global Immuno-Oncology Revenue Share by Regions (2015-2020)
Table 7. Global Immuno-Oncology Revenue (USD Million) by Regions (2020-2025)
Table 8. Global Immuno-Oncology Revenue Market Share by Regions (2020-2025)
Table 9. Global Immuno-Oncology Market Size and Growth Estimation in Various Scenarios in 2020
Table 10. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 11. Bristol-Myers Squibb Major Business
Table 12. Bristol-Myers Squibb Immuno-Oncology Total Revenue (USD Million) (2017-2018)
Table 13. Bristol-Myers Squibb SWOT Analysis
Table 14. Bristol-Myers Squibb Immuno-Oncology Product and Solutions
Table 15. Bristol-Myers Squibb Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 16. Gilead Sciences Inc. Corporate Information, Location and Competitors
Table 17. Gilead Sciences Inc. Major Business
Table 18. Gilead Sciences Inc. Immuno-Oncology Total Revenue (USD Million) (2018-2019)
Table 19. Gilead Sciences Inc. SWOT Analysis
Table 20. Gilead Sciences Inc. Immuno-Oncology Product and Solutions
Table 21. Gilead Sciences Inc. Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 22. AstraZeneca, Plc Corporate Information, Location and Competitors
Table 23. AstraZeneca, Plc Major Business
Table 24. AstraZeneca, Plc Immuno-Oncology Total Revenue (USD Million) (2017-2018)
Table 25. AstraZeneca, Plc SWOT Analysis
Table 26. AstraZeneca, Plc Immuno-Oncology Product and Solutions
Table 27. AstraZeneca, Plc Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 28. Merck & Co., Inc. Corporate Information, Location and Competitors
Table 29. Merck & Co., Inc. Major Business
Table 30. Merck & Co., Inc. Immuno-Oncology Total Revenue (USD Million) (2017-2018)
Table 31. Merck & Co., Inc. SWOT Analysis
Table 32. Merck & Co., Inc. Immuno-Oncology Product and Solutions
Table 33. Merck & Co., Inc. Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 34. Novartis Corporate Information, Location and Competitors
Table 35. Novartis Major Business
Table 36. Novartis Immuno-Oncology Total Revenue (USD Million) (2017-2018)
Table 37. Novartis SWOT Analysis
Table 38. Novartis Immuno-Oncology Product and Solutions
Table 39. Novartis Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 40. Roche AG Corporate Information, Location and Competitors
Table 41. Roche AG Major Business
Table 42. Roche AG Immuno-Oncology Total Revenue (USD Million) (2017-2018)
Table 43. Roche AG SWOT Analysis
Table 44. Roche AG Immuno-Oncology Product and Solutions
Table 45. Roche AG Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 46. Dendreon Pharmaceuticals Corporate Information, Location and Competitors
Table 47. Dendreon Pharmaceuticals Major Business
Table 48. Dendreon Pharmaceuticals Immuno-Oncology Total Revenue (USD Million) (2017-2018)
Table 49. Dendreon Pharmaceuticals SWOT Analysis
Table 50. Dendreon Pharmaceuticals Immuno-Oncology Product and Solutions
Table 51. Dendreon Pharmaceuticals Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 52. Sanofi S.A. Corporate Information, Location and Competitors
Table 53. Sanofi S.A. Major Business
Table 54. Sanofi S.A. Immuno-Oncology Total Revenue (USD Million) (2017-2018)
Table 55. Sanofi S.A. SWOT Analysis
Table 56. Sanofi S.A. Immuno-Oncology Product and Solutions
Table 57. Sanofi S.A. Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 58. Merck KGaA Corporate Information, Location and Competitors
Table 59. Merck KGaA Major Business
Table 60. Merck KGaA Immuno-Oncology Total Revenue (USD Million) (2017-2018)
Table 61. Merck KGaA SWOT Analysis
Table 62. Merck KGaA Immuno-Oncology Product and Solutions
Table 63. Merck KGaA Immuno-Oncology Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 64. Global Immuno-Oncology Revenue (USD Million) by Players (2015-2020)
Table 65. Global Immuno-Oncology Revenue Share by Players (2015-2020)
Table 66. Key Players Immuno-Oncology Revenue (USD Million) in China (2015-2020)
Table 67. Key Players Immuno-Oncology Revenue Share in China (2015-2020)
Table 68. North America Immuno-Oncology Revenue (USD Million) by Countries (2015-2020)
Table 69. North America Immuno-Oncology Revenue Market Share by Countries (2015-2020)
Table 70. North America Immuno-Oncology Revenue (USD Million) by Countries (2020-2026)
Table 71. North America Immuno-Oncology Revenue Market Share by Countries (2020-2026)
Table 72. Europe Immuno-Oncology Revenue (USD Million) by Countries (2015-2020)
Table 73. Europe Immuno-Oncology Revenue Market Share by Countries (2015-2020)
Table 74. Europe Immuno-Oncology Revenue (USD Million) by Countries (2020-2026)
Table 75. Europe Immuno-Oncology Revenue Market Share by Countries (2020-2026)
Table 76. Asia-Pacific Immuno-Oncology Revenue (USD Million) by Countries (2015-2020)
Table 77. Asia-Pacific Immuno-Oncology Revenue Market Share by Countries (2015-2020)
Table 78. Asia-Pacific Immuno-Oncology Revenue (USD Million) by Countries (2020-2026)
Table 79. Asia-Pacific Immuno-Oncology Revenue Market Share by Countries (2020-2026)
Table 80. South America Immuno-Oncology Revenue (USD Million) by Countries (2015-2020)
Table 81. South America Immuno-Oncology Revenue Market Share by Countries (2015-2020)
Table 82. South America Immuno-Oncology Revenue (USD Million) by Countries (2020-2026)
Table 83. South America Immuno-Oncology Revenue Market Share by Countries (2020-2026)
Table 84. Middle East & Africa Immuno-Oncology Revenue (USD Million) by Countries (2015-2020)
Table 85. Middle East & Africa Immuno-Oncology Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Immuno-Oncology Revenue (USD Million) by Countries (2020-2026)
Table 87. Middle East & Africa Immuno-Oncology Revenue Market Share by Countries (2020-2026)
Table 88. Global Immuno-Oncology Revenue (USD Million) by Type (2015-2020)
Table 89. Global Immuno-Oncology Revenue Share by Type (2015-2020)
Table 90. Global Immuno-Oncology Revenue Forecast by Type (2020-2025)
Table 91. Global Immuno-Oncology Market Share Forecast by Type (2020-2025)
Table 92. China Immuno-Oncology Revenue (USD Million) by Type (2015-2020)
Table 93. China Immuno-Oncology Revenue Share by Type (2015-2020)
Table 94. China Immuno-Oncology Revenue Forecast by Type (2020-2025)
Table 95. China Immuno-Oncology Market Share Forecast by Type (2020-2025)
Table 96. Global Immuno-Oncology Revenue (USD Million) by Application (2015-2020)
Table 97. Global Immuno-Oncology Revenue Share by Application (2015-2020)
Table 98. Global Immuno-Oncology Revenue Forecast by Application (2020-2025)
Table 99. Global Immuno-Oncology Market Share Forecast by Application (2020-2025)
Table 100. China Immuno-Oncology Revenue (USD Million) by Application (2015-2020)
Table 101. China Immuno-Oncology Revenue Share by Application (2015-2020)
Table 102. China Immuno-Oncology Revenue Forecast by Application (2020-2025)
Table 103. China Immuno-Oncology Market Share Forecast by Application (2020-2025)
Table 104.List of Figures
Table 105. Immuno-Oncology Picture
Table 106. Global Immuno-Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Table 107. Global Immuno-Oncology Revenue Market Share by Type in 2019
Table 108. Immune Checkpoint Inhibitors Picture
Table 109. Cytokine-Based Immunotherapy Picture
Table 110. Cancer Vaccines Picture
Table 111. CAR-T Cell Therapy Picture
Table 112. Others Picture
Table 113. Immuno-Oncology Revenue Market Share by Application in 2019
Table 114. Hospitals Picture
Table 115. Drugstores Picture
Table 116. Others Picture
Table 117. Global Immuno-Oncology Revenue and Growth Rate (2015-2025) (USD Million)
Table 118. Global Immuno-Oncology Market Size Share by Regions (2015-2025)
Table 119. Global Immuno-Oncology Market Size Share by Regions in 2019
Table 120. Global Immuno-Oncology Revenue Market Share by Regions (2020-2025)
Table 121. North America Immuno-Oncology Revenue (USD Million) and Growth Rate (2015-2025)
Table 122. Europe Immuno-Oncology Revenue (USD Million) and Growth Rate (2015-2025)
Table 123. Asia-Pacific Immuno-Oncology Revenue (USD Million) and Growth Rate (2015-2025)
Table 124. South America Immuno-Oncology Revenue (USD Million) and Growth Rate (2015-2025)
Table 125. Middle East & Africa Immuno-Oncology Revenue (USD Million) and Growth Rate (2015-2025)
Table 126. Global Immuno-Oncology Revenue Share by Players in 2019
Table 127. Global Top 5 Players Immuno-Oncology Revenue Market Share in 2019
Table 128. Top 10 Players Immuno-Oncology Revenue Market Share in Global Market in 2019
Table 129. Global Immuno-Oncology Market Size (USD Million) by Type (2015-2025)
Table 130. Global Immuno-Oncology Market Size Share by Application (2015-2025)
Table 131. North America Immuno-Oncology Market Size Share by Countries (2015-2025)
Table 132. North America Immuno-Oncology Market Size Share by Countries in 2019
Table 133. United States Immuno-Oncology Market Size (USD Million) and Forecast (2015-2025)
Table 134. Canada Immuno-Oncology Market Size (USD Million) and Forecast (2015-2025)
Table 135. Mexico Immuno-Oncology Market Size (USD Million) and Forecast (2015-2025)
Table 136. Europe Immuno-Oncology Market Size Share by Countries (2015-2025)
Table 137. Europe Immuno-Oncology Market Size Share by Countries in 2019
Table 138. Germany Immuno-Oncology Market Size (USD Million) and Forecast (2015-2025)
Table 139. France Immuno-Oncology Market Size (USD Million) and Forecast (2015-2025)
Table 140. Russia Immuno-Oncology Market Size (USD Million) and Forecast (2015-2025)
Table 141. Italy Immuno-Oncology Market Size (USD Million) and Forecast (2015-2025)
Table 142. Spain Immuno-Oncology Market Size (USD Million) and Forecast (2015-2025)
Table 143. UK Immuno-Oncology Market Size (USD Million) and Forecast (2015-2025)
Table 144. Asia Immuno-Oncology Market Size Share by Countries (2015-2025)
Table 145. Asia Immuno-Oncology Market Size Share by Countries in 2019
Table 146. China Immuno-Oncology Market Size (USD Million) and Forecast (2015-2025)
Table 147. Japan Immuno-Oncology Market Size (USD Million) and Forecast (2015-2025)
Table 148. Korea Immuno-Oncology Market Size (USD Million) and Forecast (2015-2025)
Table 149. India Immuno-Oncology Market Size (USD Million) and Forecast (2015-2025)
Table 150. Southeast Asia Immuno-Oncology Market Size (USD Million) and Forecast (2015-2025)
Table 151. South America Immuno-Oncology Market Size Share by Countries (2015-2025)
Table 152. South America Immuno-Oncology Market Size Share by Countries in 2019
Table 153. Brazil Immuno-Oncology Market Size (USD Million) and Forecast (2015-2025)
Table 154. Argentina Immuno-Oncology Market Size (USD Million) and Forecast (2015-2025)
Table 155. Middle East & Africa Immuno-Oncology Market Size Share by Countries (2015-2025)
Table 156. Middle East & Africa Immuno-Oncology Market Size Share by Countries in 2019
Table 157. Saudi Arabia Immuno-Oncology Market Size (USD Million) and Forecast (2015-2025)
Table 158. UAE Immuno-Oncology Market Size (USD Million) and Forecast (2015-2025)
Table 159. Egypt Immuno-Oncology Market Size (USD Million) and Forecast (2015-2025)
Table 160. South Africa Immuno-Oncology Market Size (USD Million) and Forecast (2015-2025)
Table 161. Global Immuno-Oncology Revenue Share by Type (2015-2020)
Table 162. China Immuno-Oncology Revenue Share by Type (2015-2020)
Table 163. Global Immuno-Oncology Revenue Share by Application (2015-2020)
Table 164. China Immuno-Oncology Revenue Share by Application (2015-2020)
Please feel free to write an email to us or to use our electronic ticketing system.
